Soleno Therapeutics, Inc. Common Stock

SLNO
Buy Open
Signal type
Buy
Status
Open
Open Price
$52.39
Stop Loss
$47.05
Performance
0.44%
Days Open
8

Signal Setup

Signal Type Buy
Status Open
Open Date Apr 7, 2026
Open Price $52.39
Stop Loss $47.05
Timespan Day

Company Profile

Name Soleno Therapeutics, Inc. Common Stock
Ticker SLNO
Market Cap $4.16B
Sector ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Latest Close $52.62
List Date Nov 13, 2014
Description

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.